ASSESSMENT OF THE EFFECT OF ADALIMUMAB ON BONE METABOLISM IN CROHN?S DISEASE

(1) HOSPITAL STA ANA Internal, Medecine, Motril (Granada), Spain

(2) CIBER in Epidemiology & Public Health, Granada, Spain

(3) Autoimmune Diseases Unit, H. S.Cecilio, Granada, Spain

(4) Gastroenterology, H. S.Cecilio, Granada, Spain

(5) Gastroenterology, H. V. de lasNieves, Granada, Spain



This item was part of the Inflammatory Bowel Disease III session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A412